NCT04390607Unknown不适用
A Research Study to Determine if a Leukocyte Esterase Electrochemical Assay Can be Used as a Marker for Periprosthetic Joint Infection
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 230
- 试验地点
- 1
- 主要终点
- Receiver Operating Curve (ROC) analysis
研究概览
简要总结
The primary objective of this study is to assess the diagnostic efficacy of the quantitative electrochemical LE biosensor for periprosthetic joint infection (PJI). The secondary objective of this study is to assess the utility of d-lactase as adjunct biomarker to LE in making a diagnosis of PJI.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •1: consecutive patients undergoing at least one of the following procedures: presumed aseptic revision arthroplasty, irrigation and debridement, radical resection for periprosthetic joint infection
排除标准
- •known active gout flare
- •existing corrosion or metallosis
- •inflammatory arthritis
- •preexisting diagnosis of infection in the same joint
- •patients undergoing second-stage procedure for infection.
结局指标
主要结局
Receiver Operating Curve (ROC) analysis
时间窗: 20 minutes
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
LE as a Marker for Periprosthetic Joint InfectionProsthetic-joint InfectionNCT05440032Center for Innovation and Research Organization160
已完成
不适用
Reliability Study Using Electrodermal Activity to Measure Sensory Processing in Children With and Without Autism Spectrum DisorderAutism Spectrum DisorderNCT02646696Barpak Geriatric Health Services, Inc. d/b/a Barpak Occupational Therapy32
终止
不适用
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant RecipientsBlood Stem Cell Transplant FailureNCT01135355Stanford University26
Enrolling By Invitation
不适用
Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographYCystic FibrosisNCT05822102National Jewish Health100
终止
不适用
Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate CancerProstate CancerNCT03256630Genomic Health®, Inc.128